SCHEMBL254908

SCHEMBL254908

O=C1CC(=O)c2cccc3cccc1c23

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.72
HPGD P15428 4/20 0.72
KDM4E B2RXH2 4/20 0.72
CES2 O00748 1/20 0.61
BCHE P06276 1/20 0.61
CES1 P23141 1/20 0.61
MCL1 Q07820 1/20 0.61
HSD17B10 Q99714 6/20 0.59
TSHR P16473 2/20 0.59
MAPK1 P28482 2/20 0.59
ATM Q13315 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
PABPC1 P11940 3/20 0.58
CASP1 P29466 2/20 0.58
CASP7 P55210 2/20 0.58
DNMT1 P26358 2/20 0.58
CYP3A4 P08684 1/20 0.58
TYMS P04818 5/20 0.56
PARP1 P09874 2/20 0.54
TP53 P04637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16230011 0.85 ALDH1A1 (0.61) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL13743285 0.85 ALDH1A1 (0.60) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL975376 0.84 ALDH1A1 (1.00) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL29383750 0.84 ALDH1A1 (1.00) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL11384416 0.82 ALDH1A1 (0.52) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL571203 0.81 ALDH1A1 (0.85) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL2617092 0.79 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL14117944 0.79 ALDH1A1 (0.53) ALDH1A1HPGDKDM4ECES2BCHE
Ammonia Solution, Strong SCHEMBL27626211 0.78 ALDH1A1 (0.81) ALDH1A1HPGDKDM4ECES2BCHE
SCHEMBL21938550 0.76 ALDH1A1 (0.50) ALDH1A1HPGDKDM4ECES2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240224999-A1 METABOLIC INHIBITORS FOR CONTROLLING BIOFILM MC US 3 LLC (US) 2024-07-11 US disclosed
WO-2024135443-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND 富士フイルム株式会社 2024-06-27 WO disclosed
WO-2024122301-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING DEVICE, PHOTOSENSOR, METHOD FOR PRODUCING IMAGING DEVICE, AND COMPOUND 富士フイルム株式会社 2024-06-13 WO disclosed
WO-2024071143-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, COMPOUND, AND COMPOUND PRODUCTION METHOD 富士フイルム株式会社 2024-04-04 WO disclosed
WO-2024071188-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, LIGHT SENSOR, AND COMPOUND 富士フイルム株式会社 2024-04-04 WO disclosed
WO-2024062871-A1 PHOTOELECTRIC CONVERSION DEVICE, IMAGING DEVICE, PHOTOSENSOR, AND COMPOUND 富士フイルム株式会社 2024-03-28 WO disclosed
EP-3757179-B1 INK COMPOSITION FOR INK JET PRINTING, IMAGE FORMING METHOD, AND RECORDED MATERIAL FUJIFILM CORP (JP) 2024-03-13 EP disclosed
CN-109937489-B Photoelectric conversion element, image pickup element, and image pickup apparatus 佳能株式会社 2024-03-08 CN disclosed
US-11913884-B2 Visible light-activated dyes and methods of use thereof WILLIAM MARSH RICE UNIVERSITY (US) 2024-02-27 US disclosed
EP-3823054-B1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORP (JP) 2024-02-14 EP disclosed
WO-2008013774-A2 NON-LINEAR OPTICAL DEVICE WITH LONG GRATING PERSISTENCY NITTO DENKO CORPORATION (JP) 2008-01-31 WO disclosed
US-7317058-B2 (Meth)acrylate polymer and non-linear optical device material composition NITTO DENKO CORPORATION (JP) 2008-01-08 US disclosed
US-7317058-B2 (Meth)acrylate polymer and non-linear optical device material composition NITTO DENKO CORPORATION (JP) 2008-01-08 US disclosed
WO-2007100369-A2 NON-LINEAR OPTICAL DEVICE MATERIAL COMPOSITION NITTO DENKO CORPORATION (JP) 2007-09-07 WO disclosed
US-7250121-B2 Non-linear optical device material composition NITTO DENKO CORPORATION (JP) 2007-07-31 US disclosed
US-7250121-B2 Non-linear optical device material composition NITTO DENKO CORPORATION (JP) 2007-07-31 US disclosed
US-7186781-B2 Fullerene-containing polymer, producing method thereof, and photorefractive composition NITTO DENKO CORPORATION (JP) 2007-03-06 US disclosed
US-7186781-B2 Fullerene-containing polymer, producing method thereof, and photorefractive composition NITTO DENKO CORPORATION (JP) 2007-03-06 US disclosed
WO-2007011911-A2 POLY(ARYLETHERIMIDES) FOR NEGATIVE BIREFRINGENT FILMS FOR LCDS AKRON POLYMER SYSTEMS (US) 2007-01-25 WO disclosed
US-20070014938-A1 Poly(aryletherimides) for negative birefringent films for LCDs AKRON POLYMER SYSTEMS, INC. 2007-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11913884-B2 Visible light-activated dyes and methods of use thereof HCCS, CLTB, ALDH1A2 ALDH1A1 311/4885HPGD 2058/4885KDM4E 3264/4885
US-20240224999-A1 METABOLIC INHIBITORS FOR CONTROLLING BIOFILM RIMKLA, HDHD5, SCD ALDH1A1 1413/4885HPGD 304/4885KDM4E 1253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.